āāāāāāāāāIndustry Articlesāāāā
āāāāāāāThe Department of Public Health (CDPH) has received numerous requests for clarification about who is authorized to order clinical laboratory tests and/or receive the test results in California. This notice is intended as an update to clarify the state and federal requirements. ā
As state hits record number of tests, California asks labs to prioritize testing turnaround for individuals who are most at risk of spreading virus to others.ā
The CDPH Division of Communicable Disease Control recently updated Section 2505 of Title 17 of the California Code of Regulations, which specifies laboratory reporting requirements for communicable diseases and conditions. This guidance document provides information about submitting reports through the California Reportable Disease Information Exchange - Electronic Lab Reporting (CalREDIE ELR) system.
āA CDC health advisory has been issued May 17, 2017 regarding potential for falsely low blood lead test results from LeadCareĀ® Analyzers.ā
There are two different types of mobile health screenings allowed under state law, each having specific requirements. Regardless of type, consumers should be aware of the risks and limitations involved, and should exercise due diligence and caution.
Notice regarding non-compliance inducement in physiciansā offices will be presented at the May 2018 CLTAC meeting.
Specified diseases and conditions are mandated by State laws and regulations to be reported by healthcare providers and laboratories to the public health authorities.
āāāāāāāāā